Bausch Health Companies | Results Presentation Deck | 48 slides

Bausch Health · 2022-11
arc beats above · slides in the middle · loops below · scroll → 1 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

48
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Attention
02
other
Open slide detailBeat · Attention
03
other
Open slide detailBeat · Attention
04
front_matter
Open slide detailBeat · Attention
05
transition
Open slide detailBeat · NeedLoop · Cost Of Inaction
06
summarize
Open slide detailBeat · NeedLoop · Cost Of Inaction
07
The slide uses a 2x2 grid layout to categorize strategic priorities by business unit.plan_implementation
Open slide detailBeat · NeedLoop · Cost Of Inaction
08
transition
Open slide detailBeat · NeedLoop · Cost Of Inaction
09
The slide uses a combination of bar charts for consolidated totals and donut charts for segment breakdowns.analyze_data
Open slide detailBeat · SatisfactionLoop · Cost Of Inaction
10
Includes non-GAAP measures and specific segment performance drivers.analyze_data
Open slide detailBeat · SatisfactionLoop · Cost Of Inaction
11
The slide uses a 2x2 grid layout to present segment-specific financial performance and qualitative drivers.analyze_data
Open slide detailBeat · SatisfactionLoop · Cost Of Inaction
12
The slide uses a combination of bar charts and donut charts to visualize revenue performance and segment composition.analyze_data
Open slide detailBeat · SatisfactionLoop · Cost Of Inaction
13
The table is split into two main blocks: 3Q performance and YTD performance, with sub-totals for Bausch Pharma + Solta and Bausch + Lomb.analyze_data
Open slide detailBeat · SatisfactionLoop · Cost Of Inaction
14
Includes a footnote regarding gain on extinguishment of debt.analyze_data
Open slide detailBeat · SatisfactionLoop · Cost Of Inaction
15
Includes constant currency adjustments and detailed footnotes regarding non-GAAP measures.analyze_data
Open slide detailBeat · SatisfactionLoop · Cost Of Inaction
16
Includes detailed footnotes regarding restricted cash, debt definitions, and non-GAAP measures.analyze_data
Open slide detailBeat · SatisfactionLoop · Cost Of Inaction
17
The slide highlights that there are no significant debt maturities until 2025.analyze_data
Open slide detailBeat · SatisfactionLoop · Cost Of Inaction
18
The chart uses a stacked bar format to represent different debt instruments maturing between 2022 and 2031.analyze_data
Open slide detailBeat · SatisfactionLoop · Cost Of Inaction
19
transition
Open slide detailBeat · SatisfactionLoop · Cost Of Inaction
20
The table uses a waterfall-style bridge logic to show the impact of Bausch + Lomb on the consolidated guidance.analyze_data
Open slide detailBeat · SatisfactionLoop · Cost Of Inaction
21
The slide highlights a change in the Adjusted Tax Rate from ~15% to ~17%.analyze_data
Open slide detailBeat · ActionLoop · Cost Of Inaction
22
transition
Open slide detailBeat · ActionLoop · Cost Of Inaction
23
The slide uses a numbered list format to outline corporate strategy.prioritize
Open slide detailBeat · ActionLoop · Cost Of Inaction
24
The slide uses a circular diagram to represent corporate values (Resilience, Execution, Focus, Accountability, Ownership, Sense of Urgency) surrounding the compsummarize
Open slide detailBeat · ActionLoop · Cost Of Inaction
25
front_matter
27
The table compares inventory levels at the end of Q2 and Q3 for two consecutive years, calculating the quarterly change.analyze_data
28
The table compares inventory levels as of year-end 2020/2021 against September year-to-date figures for 2021/2022.analyze_data
29
Includes a footnote regarding a $570 million gain related to an Exchange Offer.analyze_data
30
Includes footnotes regarding non-GAAP measures, share counts, and exclusions for cash flow.analyze_data
31
The table provides a breakdown of financial performance by segment, excluding certain corporate costs as noted in the footnote.analyze_data
32
analyze_data
33
Includes footnote regarding non-GAAP measures.analyze_data
34
Includes Bausch Health logo and page number 34.analyze_data
35
Includes detailed breakdown of non-GAAP adjustments and their impact on EPS.analyze_data
36
The slide provides a detailed breakdown of adjustments made to GAAP operating income to arrive at non-GAAP adjusted EBITA for two consecutive Q3 periods.analyze_data
37
The slide presents two identical table structures for two different time periods.analyze_data
38
Includes two separate tables: one for consolidated EBITDA and one for noncontrolling interest adjustments.analyze_data
39
Includes footnotes regarding non-GAAP measures, exchange rate impacts, and segment reporting structure.analyze_data
40
Includes footnotes regarding non-GAAP measures, exchange rate impacts, and segment reporting changes.analyze_data
41
Includes footnote disclosures regarding non-GAAP measures.analyze_data
42
Includes adjustments for asset impairments, restructuring, debt extinguishment, and other non-recurring items.analyze_data
44
Standard financial reporting disclosure slide for non-GAAP reconciliations.appendix
45
Standard financial disclosure slide explaining non-GAAP adjustments and methodology.appendix
46
Standard financial disclosure slide for non-GAAP metrics.appendix